Hautmedizin Bad Soden Studienzentrum GmbH
- Address
- lock Available on a paid plan
Psoriasis Clinical Research
The Dermatology unit at Hautmedizin Bad Soden Studienzentrum GmbH is conducting a study to assess the efficacy of an oral agent, HRO350, in patients with mild-to-moderate psoriasis. The trial compares two dose levels with placebo to identify the optimal dose for further development.
- Oral small‑molecule therapy
- Dose‑selection investigation
- Placebo‑controlled efficacy evaluation
This work aims to improve treatment options for individuals affected by skin and connective tissue disorders, advancing therapeutic choices within the field of Dermatology.
Androgenetic Alopecia Clinical Research
In a double‑blind, pivotal study, the site evaluates the safety and effectiveness of Clascoterone solution applied twice daily for adult males with androgenetic alopecia. The trial measures hair regrowth compared with a vehicle control to determine clinical benefit.
- Topical anti‑androgen treatment
- Double‑blind safety assessment
- Hair growth outcome analysis
By focusing on male pattern hair loss, the research supports the development of novel therapies in the broader therapeutic area of Skin and Connective Tissue Diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hautmedizin Bad Soden Studienzentrum GmbH
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding, efficacy and safety study of HRO350 in subjects with mild-to-moderate psoriasis (the ‘HeROPA’ study) | Arctic Bioscience AS | Phase II | Not Recruiting | Mar 2023 | Mar 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Betamethasone Valerate | 1 | Unknown | 2023-03-15 | 2023-03-15 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.